NCT00574613 - Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

September 30, 2010

Conditions

Skin Fibrosis

Interventions

DRUG

P144

Cream 0,3 ml once a day (3 months)

DRUG

placebo

Cream 0,3 ml once a day (3 months)

Trial Locations (17)

10117

Charité-Universitätsmedizin Berlin, Berlin

28041

Hospital 12 de Octubre, Madrid

31008

Clínica Universitaria de Navarra, Pamplona

50139

Azienda Ospedaliera Universitaria Careggi., Florence

50931

Universität Köln, Cologne

60590

Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt

61231

Kerckhoff Klinik, Bad Nauheim

H-7621

Magyarorszagi Irgalmasrend es Pécsi Tudomanyegyetem, Pécs

15-297

Centrum Miriada, Bialystok

40-635

Katedra i Klinika Chorób Wewnętrznych i Reumatologii, Katowice

61-545

Katedra i Klinika Reumatologiczno, Poznan

53-342

Gabinet Lekarski Internistyczno-Reumatologiczny, Wroclaw

41-803

Klinika Ftizjopneumonologii SAM, Zabrze

08036

Hospital Clínic, Barcelona

LS7 4SA

Chapel Allerton Hospital, Leeds

NW3 2QG

Royal Free Hospital, London

L9 7AL

University Hospital Aintree, Liverpool